Objective: To investigate muscarinic M1/M4 cholinergic networks in Parkinson disease dementia (PDD) and their association with changes in Mini-Mental State Examination (MMSE) after 12 weeks of treatment with donepezil. Methods: Forty-nine participants (25 PDD and 24 elderly controls) underwent 123I-QNB and 99mTc-exametazime SPECT scanning. We implemented voxel principal components (PC) analysis, producing a series of PC images of patterns of interrelated voxels across individuals. Linear regression analyses derived specific M1/M4 and perfusion spatial covariance patterns (SCPs). Results: We found an M1/M4 SCP of relative decreased binding in basal forebrain, temporal, striatum, insula, and anterior cingulate (F1,47 = 31.9, p < 0.00...
Background: Degeneration of the nucleus basalis of Meynert (NBM) and cortical cholinergic dysfuncti...
Objective: Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable t...
Objective: EEG and MEG studies in Parkinson's disease (PD) related dementia (PDD) have shown a slowi...
Objective: To investigate muscarinic M1/M4 cholinergic networks in Parkinson disease dementia (PDD) ...
We investigated changes in cerebral glucose metabolism after cholinesterase inhibitor (ChEI) therapy...
Background: The main clinical feature of dementia in Parkinson\u27s disease is a dysexecutive syndro...
Background: Degeneration of the cholinergic system plays an important role in cognitive impairment i...
BACKGROUND: The cholinergic system plays a key role in cognitive impairment in Parkinson's disease (...
Background: Degeneration of the cholinergic system plays an important role in cognitive impairment i...
Cognitive impairment is a common non-motor symptom with a debilitating effect on functional capacity...
Dysfunction and degeneration of CNS cholinergic systems is a significant component of multi-system p...
The cholinergic system arising from the basal forebrain plays an important role in cognitive perform...
We investigated changes in cerebral glucose metabolism after cholinesterase inhibitor (ChEI) therapy...
We investigated changes in cerebral glucose metabolism after cholinesterase inhibitor (ChEI) therapy...
Summary Several evidences suggest that cholinergic deficits may significantly contribute to dementi...
Background: Degeneration of the nucleus basalis of Meynert (NBM) and cortical cholinergic dysfuncti...
Objective: Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable t...
Objective: EEG and MEG studies in Parkinson's disease (PD) related dementia (PDD) have shown a slowi...
Objective: To investigate muscarinic M1/M4 cholinergic networks in Parkinson disease dementia (PDD) ...
We investigated changes in cerebral glucose metabolism after cholinesterase inhibitor (ChEI) therapy...
Background: The main clinical feature of dementia in Parkinson\u27s disease is a dysexecutive syndro...
Background: Degeneration of the cholinergic system plays an important role in cognitive impairment i...
BACKGROUND: The cholinergic system plays a key role in cognitive impairment in Parkinson's disease (...
Background: Degeneration of the cholinergic system plays an important role in cognitive impairment i...
Cognitive impairment is a common non-motor symptom with a debilitating effect on functional capacity...
Dysfunction and degeneration of CNS cholinergic systems is a significant component of multi-system p...
The cholinergic system arising from the basal forebrain plays an important role in cognitive perform...
We investigated changes in cerebral glucose metabolism after cholinesterase inhibitor (ChEI) therapy...
We investigated changes in cerebral glucose metabolism after cholinesterase inhibitor (ChEI) therapy...
Summary Several evidences suggest that cholinergic deficits may significantly contribute to dementi...
Background: Degeneration of the nucleus basalis of Meynert (NBM) and cortical cholinergic dysfuncti...
Objective: Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable t...
Objective: EEG and MEG studies in Parkinson's disease (PD) related dementia (PDD) have shown a slowi...